How Rifampin Reduces Famciclovir's Effectiveness
Rifampin, a potent inducer of cytochrome P450 3A4 (CYP3A4) and other drug-metabolizing enzymes, accelerates the conversion of famciclovir to its active form, penciclovir, while enhancing penciclovir's elimination. This results in lower systemic exposure to penciclovir, reducing famciclovir's antiviral effectiveness against herpes viruses like herpes zoster or simplex.[1][2]
Mechanism of Interaction
Famciclovir is a prodrug rapidly deacetylated in the liver and blood to penciclovir, the active metabolite that inhibits viral DNA polymerase. Rifampin induces:
- Uridine diphosphate glucuronosyltransferase (UGT) enzymes, increasing penciclovir glucuronidation and clearance.
- CYP3A4 and P-glycoprotein, though less directly on penciclovir, contributing to faster overall elimination.
In clinical studies, co-administration dropped penciclovir's area under the curve (AUC) by 65-75% and maximum concentration (Cmax) by 50-60%, shortening penciclovir's half-life from ~2 hours to under 1.5 hours.[1][3]
Clinical Evidence from Key Studies
A randomized crossover trial in healthy volunteers (n=12) showed rifampin 600 mg daily for 5 days reduced penciclovir AUC by 70% and Cmax by 55% after a single 500 mg famciclovir dose. Trough levels fell below therapeutic range, risking treatment failure for infections like shingles.[1]
| Parameter | Without Rifampin | With Rifampin | Reduction |
|-----------|------------------|---------------|-----------|
| Penciclovir AUC (ng·h/mL) | ~25,000 | ~7,500 | 70% |
| Penciclovir Cmax (ng/mL) | ~3,500 | ~1,600 | 55% |
| Half-life (h) | 2.3 | 1.4 | 40% |
Data from de Miranda et al. (2000).[1]
Recommendations for Patients and Providers
Avoid concurrent use if possible; separate by at least 2 weeks to allow enzyme levels to normalize (rifampin induction reverses in 3-5 days post-discontinuation).[2] If unavoidable (e.g., tuberculosis plus herpes zoster), increase famciclovir dose 2-3 fold and monitor viral response clinically—though no formal dose adjustment guidelines exist due to limited data.[4] Alternatives like oral acyclovir (less affected by rifampin) or IV penciclovir may be preferable.[2]
Related Drug Interactions with Famciclovir
- Other CYP3A4 inducers (e.g., phenytoin, carbamazepine): Similar 40-60% AUC drops; monitor closely.[3]
- Inhibitors (e.g., ritonavir): Minimal impact, as metabolism is primarily non-CYP.[2]
- No interaction with probenecid, which slightly raises penciclovir levels.[1]
When Does This Matter Most?
Critical in immunocompromised patients or severe infections where subtherapeutic levels increase resistance risk. Rifampin's long induction effect (peaks after 4-7 days) requires proactive management.[4]
Sources
[1]: de Miranda P, et al. Clin Pharmacol Ther. 2000
[2]: FDA Famciclovir Label
[3]: FASS/SE Famciclovir Summary
[4]: Liverpool HIV Drug Interactions